Results 231 to 240 of about 4,380 (254)

Comparative Antimicrobial Potency of Meropenem Tested Against Gram-Negative Bacilli: Report from the MYSTIC Surveillance Program in the United States (2004)

Journal of Chemotherapy, 2005
exaly  

Mysticism

2009
openaire   +2 more sources

The MYSTIC (meropenem yearly susceptibility test information collection) programme

International Journal of Antimicrobial Agents, 1999
exaly  

MYSTICISM

2010
  +4 more sources

1 Mysticism and Mystical Experiences

2016
openaire   +1 more source

Trends in antimicrobial susceptibility in UK centres: the MYSTIC Programme (1997–2002)

International Journal of Antimicrobial Agents, 2006
exaly  

MYSTIC Europe 2007: activity of meropenem and other broad-spectrum agents against nosocomial isolates

Diagnostic Microbiology and Infectious Disease, 2009
exaly  

Susceptibility of meropenem and comparators tested against 30,634 enterobacteriaceae isolated in the MYSTIC programme (1997–2003)

Diagnostic Microbiology and Infectious Disease, 2004
exaly  

Defining ‘Mysticism’ and ‘Mystical Experience’

2005
openaire   +1 more source

Prevalence and antimicrobial susceptibility data for extended-spectrum β-lactamase– and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997–2004)

Diagnostic Microbiology and Infectious Disease, 2005
exaly